Oncohistones: Exposing the nuances and vulnerabilities of epigenetic regulation

MM Mitchener, TW Muir - Molecular cell, 2022 - cell.com
Work over the last decade has uncovered a new layer of epigenetic dysregulation. It is now
appreciated that somatic missense mutations in histones, the packaging agents of genomic …

Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation

D Mancarella, C Plass - Genome medicine, 2021 - Springer
Epigenetic alterations are associated with normal biological processes such as aging or
differentiation. Changes in global epigenetic signatures, together with genetic alterations …

The dark side of histones: genomic organization and role of oncohistones in cancer

S Amatori, S Tavolaro, S Gambardella, M Fanelli - Clinical Epigenetics, 2021 - Springer
Background The oncogenic role of histone mutations is one of the most relevant discovery in
cancer epigenetics. Recurrent mutations targeting histone genes have been described in …

Histone mutations in cancer

KN Espinoza Pereira, J Shan, JD Licht… - Biochemical Society …, 2023 - portlandpress.com
Genes encoding histone proteins are recurrently mutated in tumor samples, and these
mutations may impact nucleosome stability, histone post-translational modification, or …

Natural bioactive compounds targeting histone deacetylases in human cancers: recent updates

A Bouyahya, N El Hachlafi, T Aanniz, I Bourais… - Molecules, 2022 - mdpi.com
Cancer is a complex pathology that causes a large number of deaths worldwide. Several
risk factors are involved in tumor transformation, including epigenetic factors. These factors …

Updated concepts in treatment of giant cell tumor of bone

L van der Heijden, A Lipplaa… - Current opinion in …, 2022 - journals.lww.com
Neoadjuvant denosumab is highly effective for advanced GCTB, and a short-course is
advised to facilitate surgery, whereas increased recurrence rates remain of concern …

Oncohistones: a roadmap to stalled development

S Deshmukh, A Ptack, B Krug, N Jabado - The FEBS journal, 2022 - Wiley Online Library
Since the discovery of recurrent mutations in histone H3 variants in paediatric brain tumours,
so‐called 'oncohistones' have been identified in various cancers. While their mechanism of …

Deposition of onco‐histone H3. 3‐G34W leads to DNA repair deficiency and activates cGAS/STING‐mediated immune responses

D Mancarella, H Ellinghaus… - … Journal of Cancer, 2024 - Wiley Online Library
Abstract Mutations in histone H3. 3‐encoding genes causing mutant histone tails are
associated with specific cancers such as pediatric glioblastomas (H3. 3‐G34R/V) and giant …

(B) On (e)-cohistones and the epigenetic alterations at the root of bone cancer

P Salomoni, AM Flanagan, L Cottone - Cell Death & Differentiation, 2023 - nature.com
Identification of mutations in histones in a number of human neoplasms and developmental
syndromes represents the most compelling evidence to date for a causal role of epigenetic …

H3G34-mutant gliomas—a review of molecular pathogenesis and therapeutic options

AV Nguyen, JM Soto, SM Gonzalez, J Murillo… - Biomedicines, 2023 - mdpi.com
The 2021 World Health Organization Classification of Tumors of the Central Nervous System
reflected advances in understanding of the roles of oncohistones in gliomagenesis with the …